RNS Number : 9380G
Graft Polymer (UK) PLC
15 March 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION HEREIN (THE "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION, DISTRIBUTION OR FORWARDING DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, RUSSIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, TRANSMISSION, RELEASE, DISTRIBUTION OR FORWARDING WOULD BE UNLAWFUL.THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY. IN PARTICULAR, PERSONS RECEIVING THIS ANNOUNCEMENT SHOULD READ AND UNDERSTAND THE INFORMATION PROVIDED IN THE "IMPORTANT NOTICES" SECTION OF THIS ANNOUNCEMENT. 

 

FURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN GRAFT POLYMER (UK) PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.  

 

15 March 2024  

  

Graft Polymer (UK) Plc 

(the "Company") 

  

New Chairman appointment, resignation of two directors, loan facility agreement, financial update and appointment of joint broker  

 

Board changes

 

Graft Polymer Plc (LSE:GPL) announces the resignations of two directors of the Company these being Roby Zomer, the Non-Executive Chairman of the Company, and Alex Brooks a Non-Executive Director.  Nicholas Nelson has today been appointed as a director of the Company replacing Mr Zomer as Non-Executive Chairman of the Company with immediate effect. Mr Zomer will remain as a consultant to the Company.  

 

Nicholas Nelson commenced his career in the City in 1985 in stockbroking before moving into the financial PR industry in 1999. He has previously served as a director on the boards of seven small cap quoted companies, both in executive and non-executive positions.  

 

New loan facility

 

The changes to the board follow the provision of a £100,000 working capital loan facility to the Company by Mr Nelson and another private individual (the "Loan Facility"). The Loan Facility is intended to be drawn down in full against expenses incurred by the Company as they arise, and it attracts an interest rate of 10% per month. Although the loan is technically repayable on demand, together with accumulated interest, it is mutually agreed in writing to convert all or any part of the outstanding balance of the Loan (including interest) in the form of new ordinary shares issued by the Company at a price and time agreed between the lenders and the Company. 

 

Financial update

Over recent months the Company has experienced very difficult trading conditions due to the conflicts in the Middle East, Ukraine and the Red Sea.  As a consequence, the Company's cash position has become extremely constrained thus necessitating the need for the Company to enter into the Loan Facility.  The Loan Facility will allow the Company to continue to trade and will permit the Company's audit for the year ended 31 December 2023 to be completed.

 

Appointment of joint broker

 

The Company announces the appointment of Allenby Capital as joint broker to the Company. 

 

Roby Zomer, outgoing Chairman, commented: 

 

"The shocking conflicts taking place in the Middle East, Ukraine and the Red Sea have had a major impact on the Company and conspired to undermine our business development plans. With the severe constraints on our ability to trade, our financial position has become parlous, forcing the Company to undertake an urgent review of its future direction.

 

"We thank Nicholas and the other lender for providing us with interim working capital. Nicholas's priority as the incoming Chairman is to establish sources of additional funding whilst working with the board to consider the best future for Graft Polymer." 

 

Enquiries:  

  

 

Graft Polymer (UK) Plc 

Nicholas Nelson, Non-Executive Chairman 

nelson@nexfin.org.uk 

 

Yifat Steuer, CFO and Executive Director 

 

 

Allenby Capital (Joint broker)

Nick Naylor / Liz Kirchner (Corporate Finance) 

 

Guy McDougall (Sales) 

 +44 (0) 20 3328 5656 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLGDXRXBDGSS
Graft Polymer (uk) (LSE:GPL)
過去 株価チャート
から 4 2024 まで 5 2024 Graft Polymer (uk)のチャートをもっと見るにはこちらをクリック
Graft Polymer (uk) (LSE:GPL)
過去 株価チャート
から 5 2023 まで 5 2024 Graft Polymer (uk)のチャートをもっと見るにはこちらをクリック